Valley National Advisers Inc Bio N Tech Se Transaction History

Valley National Advisers Inc

  • $557 Million
  • Q4 2024

A detailed history of Valley National Advisers Inc transactions in Bio N Tech Se stock. As of the latest transaction made, Valley National Advisers Inc holds 16 shares of BNTX stock, worth $1,674. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 16 -0.0%
Holding current value
$1,674
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024
BUY
$88.96 - $112.35 $1,423 - $1,797
16 New
16 $1,000
Q3 2021

Nov 10, 2021
BUY
$205.93 - $447.23 $3,294 - $7,155
16 New
16 $4,000

Others Institutions Holding BNTX

# of Institutions
364
Shares Held
39.7M
Call Options Held
3.01M
Put Options Held
2.01M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $25.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email